Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Payables (2016 - 2021)

Historic Payables for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q3 2021 value amounting to $322000.0.

  • Phio Pharmaceuticals' Payables fell 5660.38% to $322000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $322000.0, marking a year-over-year decrease of 5660.38%. This contributed to the annual value of $728000.0 for FY2020, which is 1001.24% down from last year.
  • Per Phio Pharmaceuticals' latest filing, its Payables stood at $322000.0 for Q3 2021, which was down 5660.38% from $348000.0 recorded in Q2 2021.
  • In the past 5 years, Phio Pharmaceuticals' Payables ranged from a high of $856000.0 in Q3 2019 and a low of $322000.0 during Q3 2021
  • For the 5-year period, Phio Pharmaceuticals' Payables averaged around $619631.6, with its median value being $672000.0 (2017).
  • In the last 5 years, Phio Pharmaceuticals' Payables surged by 14949.49% in 2017 and then plummeted by 5660.38% in 2021.
  • Quarter analysis of 5 years shows Phio Pharmaceuticals' Payables stood at $511000.0 in 2017, then increased by 7.63% to $550000.0 in 2018, then soared by 47.09% to $809000.0 in 2019, then dropped by 10.01% to $728000.0 in 2020, then tumbled by 55.77% to $322000.0 in 2021.
  • Its Payables stands at $322000.0 for Q3 2021, versus $348000.0 for Q2 2021 and $615000.0 for Q1 2021.